Table 3 Correlations between the HNCPDS, CSPDS and QOL.
HNCPDS | Cancer discrimination | Anxiety and depression | Social phobia | |
---|---|---|---|---|
CSPDS | 0.836b | 0.797b | 0.755b | 0.766b |
QOL | 0.530b | 0.371b | 0.575b | 0.465b |
Physical function | 0.362b | 0.224b | 0.391b | 0.339b |
Role function | 0.374b | 0.283b | 0.417b | 0.299b |
Emotional function | 0.382b | 0.326b | 0.337b | 0.384b |
Cognitive function | 0.235b | 0.186b | 0.180b | 0.279b |
Social function | 0.473b | 0.301b | 0.553b | 0.387b |
Fatigue | 0.218b | 0.102a | 0.288b | 0.166b |
Nausea/vomiting | 0.367b | 0.224b | 0.415b | 0.324b |
Pain | 0.341b | 0.240b | 0.394b | 0.271b |
Global health | 0.438b | 0.270b | 0.526b | 0.350b |
Dyspnoea | 0.072 | 0.072 | 0.083 | 0.042 |
Insomnia | 0.187b | 0.159b | 0.166b | 0.188b |
Appetite loss | 0.366b | 0.208b | 0.448b | 0.294b |
Constipation | 0.168b | 0.105a | 0.176a | 0.164b |
Diarrhea | 0.101a | 0.110a | 0.075 | 0.101a |
Financial difficulties | 0.373b | 0.285b | 0.388b | 0.330b |